| 1 |
26247833 | Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9. | 2016 |
1 |
| 2 |
27546373 | Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial. | 2016 Oct |
2 |
| 3 |
23682072 | Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo. | 2013 Jul |
3 |
| 4 |
19486934 | Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10. | 2009 Aug 13 |
3 |
| 5 |
12019197 | Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. | 2002 Jun |
1 |